VistaGen Therapeutics Receives Notice of Allowance for U.S. Patent for Treatment of Depression with PH10
VistaGen Therapeutics Receives FDA Fast Track Designation for Development of AV-101 as a Non-Opioid Treatment for Neuropathic Pain
VistaGen Therapeutics Acquires Worldwide License of Phase 3-Ready CNS Drug Candidate from Pherin Pharmaceuticals
Blue Jay Gold Details Fully Funded Exploration Program at Steller Gold Project in Yukon and Confirms Listing Date
The Supply Gap No One Is Filling: How CHARBONE Is Building the UHP Industrial Gas Platform Big Players Won't
QIMC Appears Before Quebec National Assembly on Bill 17, Highlighting Quebec's Natural Hydrogen Potential
